Product Description
Mechanisms of Action: COX2 Inhibitor
Novel Mechanism: No
Modality: Small Molecule
Route of Administration: Oral
FDA Designation: None *
Approval Status: Not Approved
Approved Countries: Brazil | Chile | Colombia | Dominican Republic | Germany | India | New Zealand | Norway | Peru | Portugal | Slovenia | Sweden | United Kingdom | Venezuela
Approved Indications: None
Known Adverse Events: None
Company: Novartis
Company Location: BASEL V8 CH 4056
Company CEO: Vasant Narasimhan
Additional Commercial Interests: None
Clinical Description
Countries in Clinic:
Active Clinical Trial Count:
Highest Development Phases
Phase 4: Musculoskeletal Pain|Hypertension|Osteoarthritis|Healthy Volunteers|Pain Unspecified|Acute Pain
Phase 3: Osteoarthritis, Knee|Osteoarthritis|Arthritis, Rheumatoid|Osteoarthritis, Hip|Pain Unspecified
Phase 2: Kidney Failure, Chronic|Arthralgia
Trial |
Phase |
Trial Status |
Disease |
Primary Completion Date |
Probability of Success |
|---|---|---|---|---|---|
| 2006-7041-83/hah | N/A |
Not yet recruiting |
Pregnancy Outcomes |
2019-12-01 |
|
| PEMEX-805415-00-2 | P2 |
Terminated |
Kidney Failure, Chronic|Arthralgia |
2012-11-01 |
|
| ND | P4 |
Completed |
Unknown |
2010-10-16 |
|
| 2005-005949-19 | P3 |
Completed |
Pain Unspecified |
2006-12-15 |
|
| 2005-002772-14 | P3 |
Completed |
Osteoarthritis, Hip |
2006-10-13 |
|
| CCOX189A2367 | P3 |
Completed |
Osteoarthritis, Hip |
2006-10-01 |
|
| 2005-005422-31 | P4 |
Completed |
Healthy Volunteers |
2006-09-29 |
|
| 2005-003286-17 | P4 |
Completed |
Osteoarthritis |
2006-09-27 |
|
| CCOX189A2428 | P4 |
Completed |
Hypertension|Osteoarthritis |
2006-09-01 |
|
| CCOX189A2474 | P4 |
Completed |
Acute Pain |
2006-05-01 |
|
| 2005-000229-51 | P3 |
Completed |
Osteoarthritis |
2005-11-11 |
|
| CCOX189A2369 | P3 |
Completed |
Osteoarthritis |
2005-11-01 |
|
| CCOX189A2365 | P3 |
Completed |
Osteoarthritis, Knee|Arthritis, Rheumatoid |
2005-07-01 |
|
| CCOX189A2360E1 | P3 |
Completed |
Osteoarthritis, Knee |
2004-12-01 |
|
| CCOX189A2361E1 | P3 |
Completed |
Osteoarthritis, Knee |
2004-11-01 |
|
| CCOX189A2360 | P3 |
Completed |
Osteoarthritis, Knee |
2004-03-01 |
|
| CCOX189A2361 | P3 |
Completed |
Osteoarthritis, Knee |
2004-02-01 |
|
| CCOX189A2307 | P3 |
Completed |
Osteoarthritis |
2001-03-01 |
|
| CCOX189A2301 | P3 |
Completed |
Osteoarthritis |
2001-02-01 |
|
| CCOX189AGB02 | P4 |
Completed |
Musculoskeletal Pain |
None |
|
| CCOX189A2425 | P4 |
Completed |
Healthy Volunteers |
None |
|
| 50 mg Three Times a Day | P4 |
Completed |
Unknown |
None |
|
| CCOX189A2475 | P4 |
Completed |
Hypertension|Osteoarthritis |
None |
|
| 2004-001132-23 | P3 |
Completed |
Osteoarthritis |
None |
|
| CCOX189A2427 | P4 |
Completed |
Pain Unspecified |
None |